CYCLO THERAPEUTICS INC's ticker is CYTH and the CUSIP is 23254X201. A total of 15 filers reported holding CYCLO THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,724 | +1.6% | 32,200 | +13.8% | 0.00% | – |
| Q2 2023 | $44,997 | +89.1% | 28,300 | 0.0% | 0.00% | – |
| Q1 2023 | $23,800 | -70.4% | 28,300 | -50.0% | 0.00% | – |
| Q4 2022 | $80,372 | +46.1% | 56,600 | +100.0% | 0.00% | – |
| Q3 2022 | $55,000 | -3.5% | 28,300 | 0.0% | 0.00% | – |
| Q2 2022 | $57,000 | -36.7% | 28,300 | 0.0% | 0.00% | – |
| Q1 2022 | $90,000 | -15.1% | 28,300 | 0.0% | 0.00% | – |
| Q4 2021 | $106,000 | -47.0% | 28,300 | -4.4% | 0.00% | – |
| Q3 2021 | $200,000 | -56.2% | 29,600 | -33.8% | 0.00% | – |
| Q2 2021 | $457,000 | – | 44,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 22,247 | $83,000 | 0.01% |
| Renaissance Technologies | 66,300 | $247,000 | 0.00% |
| ROYAL BANK OF CANADA | 746 | $3,000 | 0.00% |
| VANGUARD GROUP INC | 254,301 | $948,000 | 0.00% |
| UBS Group AG | 12,911 | $48,000 | 0.00% |
| IFP Advisors, Inc | 13 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 900 | $3,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 36 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 46,848 | $174,000 | 0.00% |